Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Palliative Treatment for Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Retrospective Analysis

PURPOSE: This study aimed to evaluate the efficacy and safety of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy beyond standard treatment for anthracycline- and taxane-pretreated metastatic breast cancer (MBC). METHODS: We consecutively enrolled 158 MBC patients who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin Hyun, Im, Seock-Ah, Byun, Ja Min, Kim, Ki Hwan, Kim, Jin-Soo, Choi, In Sil, Kim, Hee-Jun, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Oh, Do Youn, Kim, Tae-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743994/
https://www.ncbi.nlm.nih.gov/pubmed/29285039
http://dx.doi.org/10.4048/jbc.2017.20.4.347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743994/
https://www.ncbi.nlm.nih.gov/pubmed/29285039
http://dx.doi.org/10.4048/jbc.2017.20.4.347

Ejemplares similares